| tDCS and Speech Therapy for Motor Speech Disorders Caused by FTLD Syndromes: a Feasibility Study (NCT04883229) | University of California, San Francisco | 2022-07-01 |
| Community Outreach for Palliative Engagement -- Parkinson Disease (NCT05222386) | University of Rochester | 2022-04-26 |
| Biomarkers in Parkinsonian Syndromes (NCT06501469) | Non-profit organization for scientific research in Parkinson's disease and related disorders | 2022-03-23 |
| Test-retest Study With [18F]PI-2620 in PSP-RS and NDC (NCT05187546) | Life Molecular Imaging GmbH | 2022-03-10 |
| Cholinergic Mechanisms of Attentional-motor Integration and Gait Dysfunction in Parkinson Disease (UDALL) (NCT05459753) | University of Michigan | 2022-03-01 |
| Sociodemographic Factors and Criminal Behaviour Preceding Neurodegenerative Disease - Retrospective Register Study (NCT06209515) | Kuopio University Hospital | 2022-01-01 |
| The MOTIVE-PSP Initiative (Progressive Supranuclear Palsy) (NCT04691635) | University of Salerno | 2022-01-01 |
| Study of Comprehensive ANd Multimodal Marker-based Cohort of Progressive Supranuclear Palsy(PSP) (NCT05579301) | Seoul National University Hospital | 2021-12-19 |
| A Phase 2a Study of TPN-101 in Patients With Progressive Supranuclear Palsy (PSP) (NCT04993768) | Transposon Therapeutics, Inc. | 2021-12-12 |
| Safety and Efficacy of Droxidopa for Fatigue in Patients With Parkinsonism (NCT03446807) | Loma Linda University | 2021-12-01 |
| Evaluation of the Efficacy of a Two-week EMST on Dysphagia in Parkinsonian Patients (NCT05139342) | Kliniken Beelitz GmbH | 2021-11-15 |
| Automated Imaging Differentiation of Parkinsonism (NCT05913687) | University of Florida | 2021-07-22 |
| Optimization of Morphomer-based Alpha-synuclein PET Tracers (NCT05067192) | Skane University Hospital | 2021-07-15 |
| The Study to Evaluate the Safety and Efficacy of Spinal Cord Stimulation on Progressive Supranuclear Palsy (NCT04367116) | Huashan Hospital | 2021-07-01 |
| RT001 in Patients With Progressive Supranuclear Palsy (PSP) PROGRESSIVE SUPRANUCLEAR PALSY (NCT04937530) | Biojiva LLC | 2021-06-23 |
| Evaluation of [18F]APN-1607 as a PET Biomarker (NCT05005819) | Invicro | 2021-05-25 |
| Personalized Parkinson Project PSP Cohort (NCT05501431) | Radboud University Medical Center | 2021-05-01 |
| Mobility in Atypical Parkinsonism: a Trial of Physiotherapy (NCT04608604) | Victoria Sidoroff | 2021-02-01 |
| Rho Kinase (ROCK) Inhibitor in Tauopathies - 1 (NCT04734379) | Woolsey Pharmaceuticals | 2021-01-22 |
| Complex Eye Movements in Parkinson's Disease and Related Movement Disorders (NCT04925622) | Saccadous, Inc. | 2021-01-04 |
| Evaluation of Tolfenamic Acid in Individuals With PSP at 12-Weeks (NCT04253132) | NeuroTau, Inc. | 2021-01-01 |
| Tau Protein and SV2a Imaging in Patients With Tau Protein-related Diseases (NCT05260151) | Xuanwu Hospital, Beijing | 2020-11-18 |
| A Study to Test the Safety and Tolerability of Long-term UCB0107 Administration in Study Participants With Progressive Supranuclear Palsy (NCT04658199) | UCB Biopharma SRL | 2020-11-16 |
| Evaluation of Imaging Characteristics of [18F]PI-2620 PET in AD and PSP Patients Using High and Low Specific Activity (NCT04715750) | Life Molecular Imaging GmbH | 2020-11-12 |
| A Study to Assess Tolerability, Safety, Pharmacokinetics and Effect of AZP2006 in Patients With PSP (NCT04008355) | AlzProtect SAS | 2020-06-22 |
| Image Characteristic and Longitudinal Follow up of 18F-PMPBB3 (APN-1607) PET for Progressive Supranuclear Palsy (NCT04541836) | Chang Gung Memorial Hospital | 2020-06-15 |
| A Study to Test the Safety and Tolerability of UCB0107 in Study Participants With Progressive Supranuclear Palsy (PSP) (NCT04185415) | UCB Biopharma SRL | 2019-12-03 |
| Trial of Parkinson's And Zoledronic Acid (NCT03924414) | California Pacific Medical Center Research Institute | 2019-11-15 |
| Neurodegenerative Diseases Registry (NCT04472130) | Vincent Mok | 2019-10-09 |
| Study of NBMI Treatment in Patients With Atypical Parkinsons (PSP or MSA) (NCT04184063) | EmeraMed | 2019-09-16 |
| Quality of Life of the Patient and the Burden of the Caregiver in Progressive Supranuclear Palsy (NCT03638505) | Assistance Publique Hopitaux De Marseille | 2019-07-04 |
| Tau Imaging With JNJ067 (NCT03926702) | University of California, Berkeley | 2019-06-18 |
| Facilitating Diagnostics and Prognostics of Parkinsonian Syndromes Using Neuroimaging (NCT03872102) | University of Texas Southwestern Medical Center | 2019-03-28 |
| Misfolded Proteins in the Skin of People With Parkinson's Disease and Other Parkinsonism (NCT04518059) | University Hospitals Cleveland Medical Center | 2019-03-12 |
| Brain Network Activation in Patients With Movement Disorders (NCT03269201) | Sheba Medical Center | 2019-03-01 |
| Subcutaneous Apomorphine in the Treatment of Progressive Supranuclear Palsy and Cortico Basal Degeneration (APOPARKA) (NCT04786158) | Fondation Ophtalmologique Adolphe de Rothschild | 2018-12-01 |
| In-Home Care for Patients With PSP and Related Disorders (NCT03552484) | Rush University Medical Center | 2018-05-30 |
| Phase 1 Test-retest Evaluation of [18F]MNI-958 PET (NCT03545789) | Invicro | 2018-03-12 |
| 18F-PM-PBB3 PET Study in Tauopathy Including Alzheimer's Disease, Other Dementias and Normal Controls (NCT03625128) | Chang Gung Memorial Hospital | 2018-01-02 |
| Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia (NCT03225144) | National Institute of Neurological Disorders and Stroke (NINDS) | 2017-10-11 |
| Systematic Assessment of Laryngopharyngeal Function in Patients With Neurodegenerative Diseases (NCT04706234) | Kliniken Beelitz GmbH | 2017-09-01 |
| Cerebellar rTMS Theta Burst for Postural Instability in Progressive Supranuclear Palsy (NCT04222218) | Fondazione Europea di Ricerca Biomedica Ferb Onlus | 2017-06-01 |
| The Swedish BioFINDER 2 Study (NCT03174938) | Skane University Hospital | 2017-05-15 |
| A Study to Assess Efficacy, Safety, Tolerability, and Pharmacokinetics of ABBV-8E12 in Subjects With Progressive Supranuclear Palsy (PSP) (NCT02985879) | AbbVie | 2016-12-12 |
| Phase 0 Evaluation of [18F]MNI-958 as a Potential PET Radioligand for Imaging Tau Protein in the Brain (NCT03058965) | Molecular NeuroImaging | 2016-11-29 |
| Evaluation of [18F]MNI-952 as a Potential PET Radioligand for Imaging Tau Protein in the Brain (NCT03080051) | Molecular NeuroImaging | 2016-08-01 |
| Neurologic Stem Cell Treatment Study (NCT02795052) | MD Stem Cells | 2016-06-01 |
| Biomarkers in Neural Disorders (NCT02761707) | University of Pennsylvania | 2016-06-01 |
| Gait Analysis in Neurological Disease (NCT02994719) | Beth Israel Deaconess Medical Center | 2016-03-01 |
| Neuropsychological Evaluation for Early Diagnosis of PSP (NCT03478124) | Ospedale Generale Di Zona Moriggia-Pelascini | 2016-01-01 |
| A Molecular Anatomic Imaging Analysis of Tau in Progressive Supranuclear Palsy (NCT02605785) | Mayo Clinic | 2015-11-01 |
| Multiple Ascending Dose Study of Intravenously Administered BMS-986168 (BIIB092) in Patients With Progressive Supranuclear Palsy (NCT02460094) | Biogen | 2015-10-02 |
| Pathophysiology of Gait and Posture in Progressive Supranuclear Palsy (NCT04096651) | Centre Hospitalier Universitaire de la Guadeloupe | 2015-09-28 |
| Diagnosing Frontotemporal Lobar Degeneration (NCT02964637) | University Health Network, Toronto | 2015-08-01 |
| Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy (NCT02494024) | C2N Diagnostics | 2015-07-01 |
| A 6 Month, Open-Label, Pilot Futility Clinical Trial of Oral Salsalate for Progressive Supranuclear Palsy (NCT02422485) | Adam Boxer | 2015-04-01 |
| Study of the Neural Basis of Analogical Reasoning (NCT02236832) | Institut National de la Santé Et de la Recherche Médicale, France | 2015-02-01 |
| Tau Imaging in Subjects With Progressive Supranuclear Palsy, Corticobasal Degeneration and Healthy Volunteers (NCT02167594) | Avid Radiopharmaceuticals | 2014-08-12 |
| Rehabilitation in Patients With Progressive Supranuclear Palsy (NCT02109393) | Ospedale Generale Di Zona Moriggia-Pelascini | 2014-04-01 |
| Biomarkers in Parkinsonian Syndromes (NCT02114242) | University Hospital, Bordeaux | 2013-12-16 |
| Deep TMS for the Treatment of Patients With Parkinson's Disease and Progressive Supranuclear Palsy (NCT02734485) | IRCCS San Raffaele Roma | 2013-10-01 |
| Foot Mechanical Stimulation for Treatment of Gait and Gait Related Disorders in Parkinson's Disease and Progressive Supranuclear Palsy. (NCT01815281) | IRCCS San Raffaele Roma | 2013-07-01 |
| 2-(1-{6-[(2-[F-18]Fluoroethyl) (Methyl)Amino]-2-naphthyl} Ethylidene) Malononitrile-PET for in Vivo Diagnose of Tauopathy in Unclassified Parkinsonism (NCT02214862) | Fundacion Clinic per a la Recerca Biomédica | 2013-03-01 |
| Clinical Trial to Evaluate Bone Marrow Stem Cell Therapy for PSP, a Rare Form of Parkinsonism (NCT01824121) | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | 2012-12-01 |
| Magnetic Resonance Imaging in the Diagnosis of Parkinsonian Syndromes (NCT02445469) | University Hospital, Montpellier | 2012-12-01 |
| Modifiable Variables in Parkinsonism (MVP) (NCT02194816) | Bastyr University | 2012-09-01 |
| Robot Walking Rehabilitation in Parkinson's Disease (NCT01668407) | IRCCS San Raffaele Roma | 2012-03-30 |
| Postural Instability in Progressive Supranuclear Palsy (NCT01563276) | Oregon Health and Science University | 2011-12-01 |
| Evaluating Cerebrospinal Fluid Biomarkers in Alzheimer's, Progressive Supranuclear Palsy Subjects, and Controls (NCT01348061) | KineMed | 2011-07-01 |
| 4 Repeat Tauopathy Neuroimaging Initiative (NCT01804452) | University of California, San Francisco | 2011-01-10 |
| Analysis of the Enteric Nervous System Using Colonic Biopsies (NCT01353183) | Nantes University Hospital | 2010-11-01 |
| Study to Evaluate the Safety and Efficacy of Davunetide for the Treatment of Progressive Supranuclear Palsy (NCT01110720) | Allon Therapeutics | 2010-10-01 |
| Alpha-lipoic Acid/L-acetyl Carnitine for Progressive Supranuclear Palsy (NCT01537549) | Weill Medical College of Cornell University | 2010-09-14 |
| Efficacy, Tolerability and Safety of Azilect in Subjects With Progressive Supranuclear Palsy (NCT01187888) | Prof. Dr. Stefan Lorenzl | 2010-01-01 |
| Davunetide (AL-108) in Predicted Tauopathies - Pilot Study (NCT01056965) | University of California, San Francisco | 2010-01-01 |
| Safety, Tolerability, and Efficacy of Two Different Oral Doses of NP031112 Versus Placebo in the Treatment of Patients With Mild-to-Moderate Progressive Supranuclear Palsy (NCT01049399) | Noscira SA | 2009-12-01 |
| Repetitive Transcranial Magnetic Stimulation (TMS) for Progressive Supranuclear Palsy and Corticobasal Degeneration (NCT01174771) | University of California, Los Angeles | 2008-10-01 |
| A Pilot Trial of Lithium in Subjects With Progressive Supranuclear Palsy or Corticobasal Degeneration (NCT00703677) | Westat | 2008-09-01 |
| Efficacy Study for Treatment of Dementia in Progressive Supranuclear Palsy (NCT00522015) | University Hospital Tuebingen | 2008-02-01 |
| Research of Biomarkers in Parkinson Disease (NCT00465790) | Institut National de la Santé Et de la Recherche Médicale, France | 2007-10-01 |
| Diagnostic and Prognostic Biomarkers in Parkinson Disease (NCT00653783) | The Parkinson Study Group | 2007-08-01 |
| Trial of Valproic Acid in Patients With Progressive Supranuclear Palsy (Depakine) (NCT00385710) | Nantes University Hospital | 2006-11-01 |
| Effects of Coenzyme Q10 in Progressive Supranuclear Palsy (PSP) (NCT00382824) | Lahey Clinic | 2006-09-01 |
| Risk Factors for Progressive Supranuclear Palsy (PSP) (NCT00431301) | University of Louisville | 2006-08-01 |
| Study About Safety and Efficacy of Coenzyme Q10 in Progressive Supranuclear Palsy (NCT00328874) | German Parkinson Study Group (GPS) | 2006-05-01 |
| A Pilot Clinical Trial of Pyruvate, Creatine, and Niacinamide in Progressive Supranuclear Palsy. (NCT00605930) | University of Louisville | 2004-04-01 |
| Cognitive Impairement In Frontotemporal Dementia (NCT03452956) | University of Pennsylvania | 2003-07-01 |
| Continuously Infused Recombinant-Methionyl Human Glial Cell Line-Derived Neurotrophic Factor (GDNF) to Treat Progressive Supranuclear Palsy (NCT00005903) | National Institute of Neurological Disorders and Stroke (NINDS) | 2000-06-01 |
| Neuroprotection and Natural History in Parkinson's Plus Syndromes (NNIPPS) (NCT00211224) | King's College London | 2000-04-01 |